CN103070333A - 蚕虫草(活性物质)多糖的萃取及其胶囊配制方法 - Google Patents
蚕虫草(活性物质)多糖的萃取及其胶囊配制方法 Download PDFInfo
- Publication number
- CN103070333A CN103070333A CN201210548998XA CN201210548998A CN103070333A CN 103070333 A CN103070333 A CN 103070333A CN 201210548998X A CN201210548998X A CN 201210548998XA CN 201210548998 A CN201210548998 A CN 201210548998A CN 103070333 A CN103070333 A CN 103070333A
- Authority
- CN
- China
- Prior art keywords
- silkworm
- polysaccharide
- capsule
- cordyceps
- caterpillar fungus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 31
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 31
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 31
- 239000002775 capsule Substances 0.000 title claims abstract description 27
- 238000000605 extraction Methods 0.000 title claims abstract description 14
- 241000190633 Cordyceps Species 0.000 title abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 239000013543 active substance Substances 0.000 title abstract 3
- 239000000284 extract Substances 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000012141 concentrate Substances 0.000 claims abstract description 13
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 11
- 244000197580 Poria cocos Species 0.000 claims abstract description 11
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 11
- 239000000047 product Substances 0.000 claims abstract description 11
- 230000003712 anti-aging effect Effects 0.000 claims abstract description 10
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 8
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 5
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 5
- 229920001353 Dextrin Polymers 0.000 claims abstract description 5
- 239000004375 Dextrin Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 5
- 235000019425 dextrin Nutrition 0.000 claims abstract description 5
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 229940082787 spirulina Drugs 0.000 claims abstract description 5
- 238000001694 spray drying Methods 0.000 claims abstract description 5
- 235000013311 vegetables Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 4
- 240000000249 Morus alba Species 0.000 claims abstract description 3
- 239000012153 distilled water Substances 0.000 claims abstract description 3
- 238000001556 precipitation Methods 0.000 claims abstract description 3
- 241000255789 Bombyx mori Species 0.000 claims description 64
- 241000233866 Fungi Species 0.000 claims description 40
- 240000001307 Myosotis scorpioides Species 0.000 claims description 40
- 241001264174 Cordyceps militaris Species 0.000 claims description 18
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 18
- 235000013305 food Nutrition 0.000 claims description 13
- 230000002255 enzymatic effect Effects 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 244000046146 Pueraria lobata Species 0.000 claims description 10
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 9
- 241000195493 Cryptophyta Species 0.000 claims description 9
- 239000011149 active material Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 244000241838 Lycium barbarum Species 0.000 claims description 8
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 8
- 241000218231 Moraceae Species 0.000 claims description 8
- 240000000588 Hericium erinaceus Species 0.000 claims description 6
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 6
- 239000004365 Protease Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 229940088598 enzyme Drugs 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000013049 sediment Substances 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 102000013142 Amylases Human genes 0.000 claims description 2
- 240000006439 Aspergillus oryzae Species 0.000 claims description 2
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 2
- 108010004032 Bromelains Proteins 0.000 claims description 2
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 240000008669 Hedera helix Species 0.000 claims description 2
- 244000302512 Momordica charantia Species 0.000 claims description 2
- 235000009811 Momordica charantia Nutrition 0.000 claims description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims description 2
- 235000018365 Momordica dioica Nutrition 0.000 claims description 2
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 241000238370 Sepia Species 0.000 claims description 2
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 235000019835 bromelain Nutrition 0.000 claims description 2
- 108010089934 carbohydrase Proteins 0.000 claims description 2
- 229940106157 cellulase Drugs 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 108010087005 glusulase Proteins 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019419 proteases Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000009835 boiling Methods 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 25
- 230000000694 effects Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 7
- 229940127003 anti-diabetic drug Drugs 0.000 description 7
- 239000003472 antidiabetic agent Substances 0.000 description 7
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 7
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000002798 bone marrow cell Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000031320 Teratogenesis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 230000003541 clastogenic effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000002601 glomerular mesangium Anatomy 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- ZDPUTNZENXVHJC-UUOKFMHZSA-N guanosine 3'-monophosphate Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O ZDPUTNZENXVHJC-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 210000002311 liver mitochondria Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000002476 tumorcidal effect Effects 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
淋巴细胞转化 CPM±SO |
烧伤对照 6 11968±3319 |
7 3275±794 |
腹腔巨噬细胞吞噬运动 吞噬百分数 指数 |
烧伤对照 6 64.0±6.11 2.51±0.17 |
蚕虫草 7 55.0±11.2 3.42±0.21 |
组别 | 剂量(g/kg)体重 | 动物数 | 受检精子数 | 畸变数 | 畸变率(%) |
1 | 0.0 | 5 | 5000 | 0.95 | |
2 | 0.2 | 5 | 5000 | 0.98 | |
3 | 1.0 | 5 | 5000 | 0.96 | |
4 | 5.0 | 5 | 5000 | 0.95 | |
5 | 对照(阳性) | 5 | 5000 | 3.68 |
组别 | 剂量(g/kg) | 动物数(只) | 微核出现率% |
1 | 0.0 | 10 | 1.20 |
2 | 0.2 | 10 | 1.10 |
3 | 1.0 | 10 | 0.9 |
4 | 5.0 | 10 | 1.2 |
5 | 阳性对照 | 10 | 19.8 |
验测数 | 男性6人 | 女性4人 | 下降率(平均值) |
起始数 | 8.5 | 8.2 | |
4天后 | 8.5 | 8.3 | |
8天后 | 8.4 | 8.1 | |
12天后 | 7.6 | 7.6 | |
16天后 | 7.2 | 7.0 | |
20天后 | 6.7 | 6.5 |
验测时间 | 男性 | 女性 | 减少降糖药量 |
起始时间 | 8.8 | 8.9 | —— |
第十天 | 8.3 | 8.4 | —— |
20天 | 7.0 | 7.2 | 原用降糖药减少1∕3 |
30天 | 6.5 | 6.6 | 原用降糖药减少2∕3 |
40天 | 6.4 | 6.5 | 原用降糖药减少2∕3 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210548998.XA CN103070333B (zh) | 2012-12-18 | 2012-12-18 | 蚕虫草多糖的萃取及其胶囊配制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210548998.XA CN103070333B (zh) | 2012-12-18 | 2012-12-18 | 蚕虫草多糖的萃取及其胶囊配制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103070333A true CN103070333A (zh) | 2013-05-01 |
CN103070333B CN103070333B (zh) | 2014-05-28 |
Family
ID=48147195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210548998.XA Expired - Fee Related CN103070333B (zh) | 2012-12-18 | 2012-12-18 | 蚕虫草多糖的萃取及其胶囊配制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103070333B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103772460A (zh) * | 2014-02-14 | 2014-05-07 | 江苏省中国科学院植物研究所 | 蚕虫草(活性物质)虫草素的提取工艺 |
CN104643032A (zh) * | 2015-02-04 | 2015-05-27 | 北京福原环球生物科技有限公司 | 药用菌有效成分的提取方法 |
CN108618084A (zh) * | 2018-05-09 | 2018-10-09 | 仲景食品股份有限公司 | 一种菇酶解粉及其制备方法 |
CN114196549A (zh) * | 2021-11-22 | 2022-03-18 | 上海应用技术大学 | 一种蛹虫草菌糠发酵液及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0067000A2 (en) * | 1981-05-22 | 1982-12-15 | Snow Brand Milk Products Co. Ltd. | Production of a nitrogen-containing polysaccharide having antitumour activity |
CN1383887A (zh) * | 2002-06-19 | 2002-12-11 | 李祥麟 | 抗衰老药物组合物及其制备方法 |
CN1524953A (zh) * | 2002-06-19 | 2004-09-01 | 李祥麟 | 抗衰老药物组合物及其制备方法 |
CN1602758A (zh) * | 2004-11-10 | 2005-04-06 | 李祥麟 | 解酒营养液(饮料)、醒酒胶囊的制作方法 |
KR20050040901A (ko) * | 2005-04-13 | 2005-05-03 | 이승정 | 큰번데기 동충하초로부터 분리된 다당체 분획 추출물을함유하는 당뇨병 예방 및 개선을 위한 조성물 |
KR100871399B1 (ko) * | 2007-02-20 | 2008-12-02 | 원광대학교산학협력단 | 면역 활성 증강용 동충하초 액체배양물로부터 얻어지는균체내 다당체와 균체외 다당체 및 그 생산 최적 배양조건 |
-
2012
- 2012-12-18 CN CN201210548998.XA patent/CN103070333B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0067000A2 (en) * | 1981-05-22 | 1982-12-15 | Snow Brand Milk Products Co. Ltd. | Production of a nitrogen-containing polysaccharide having antitumour activity |
CN1383887A (zh) * | 2002-06-19 | 2002-12-11 | 李祥麟 | 抗衰老药物组合物及其制备方法 |
CN1524953A (zh) * | 2002-06-19 | 2004-09-01 | 李祥麟 | 抗衰老药物组合物及其制备方法 |
CN1602758A (zh) * | 2004-11-10 | 2005-04-06 | 李祥麟 | 解酒营养液(饮料)、醒酒胶囊的制作方法 |
KR20050040901A (ko) * | 2005-04-13 | 2005-05-03 | 이승정 | 큰번데기 동충하초로부터 분리된 다당체 분획 추출물을함유하는 당뇨병 예방 및 개선을 위한 조성물 |
KR100871399B1 (ko) * | 2007-02-20 | 2008-12-02 | 원광대학교산학협력단 | 면역 활성 증강용 동충하초 액체배양물로부터 얻어지는균체내 다당체와 균체외 다당체 및 그 생산 최적 배양조건 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103772460A (zh) * | 2014-02-14 | 2014-05-07 | 江苏省中国科学院植物研究所 | 蚕虫草(活性物质)虫草素的提取工艺 |
CN103772460B (zh) * | 2014-02-14 | 2016-02-10 | 江苏省中国科学院植物研究所 | 蚕虫草中虫草素的提取工艺 |
CN104643032A (zh) * | 2015-02-04 | 2015-05-27 | 北京福原环球生物科技有限公司 | 药用菌有效成分的提取方法 |
CN108618084A (zh) * | 2018-05-09 | 2018-10-09 | 仲景食品股份有限公司 | 一种菇酶解粉及其制备方法 |
CN114196549A (zh) * | 2021-11-22 | 2022-03-18 | 上海应用技术大学 | 一种蛹虫草菌糠发酵液及其制备方法 |
CN114196549B (zh) * | 2021-11-22 | 2023-08-22 | 杭州慧农生物科技有限公司 | 一种蛹虫草菌糠发酵液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103070333B (zh) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103027231B (zh) | 一种复合益生菌发酵中草药活性保健液及其制备方法 | |
CN103103057A (zh) | 一种蚕虫草营养露酒的配制方法 | |
CN104872758B (zh) | 蝉花牛蒡口服液的制备方法 | |
CN108272073A (zh) | 一种减肥代餐粉及其制备方法 | |
CN103315362B (zh) | 一种茯苓固态发酵功能饮品及制备方法 | |
CN105310075A (zh) | 一种辅助降血脂的纳豆红曲保健食品制备方法 | |
CN102994305B (zh) | 用蛹虫草、茧提取物制备保健食(疗)品之营养露酒的方法 | |
CN103070333B (zh) | 蚕虫草多糖的萃取及其胶囊配制方法 | |
CN106615431A (zh) | 一种菊芋片茶及其制作方法 | |
CN107267403A (zh) | 羊肚菌菌丝体的培养基、羊肚菌复合菌丝体及制备方法 | |
CN102613331B (zh) | 蜜环菌发酵茶、蜜环菌发酵茶组合物及其制备及方法 | |
CN101703296B (zh) | 一种榆黄蘑饮料及其制备方法 | |
CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
CN107343889A (zh) | 一种用于治疗第1型或第2型糖尿病的蝙蝠蛾拟青霉菌发酵培养物 | |
CN103169067A (zh) | 灵芝的创新加工技术 | |
CN112535287A (zh) | 一种复方食用菌口服液及其制备工艺 | |
CN102631494B (zh) | 一种提高免疫力、抗疲劳的中药组合物 | |
CN103932180A (zh) | 一种缓解压力及抗疲劳的保健食品及其二步发酵制备方法 | |
CN103932172B (zh) | 一种虫草保健品及其制备方法 | |
CN102613367B (zh) | 一种松茸发酵茶及其制备方法 | |
CN102078600B (zh) | 抗癌复方灵芝组合物、其用途和包含其的药物组合物 | |
CN111165694B (zh) | 一种复合黑菊芋功能营养液及其制备方法 | |
KR20220020147A (ko) | 상황버섯균사체 추출물 또는 상황버섯균사체 추출물 분말의 제조방법 및 이들을 유효성분으로 포함하는 면역 증강용 조성물 | |
CN106511401A (zh) | 戴氏虫草菌丝体多糖的制备方法及应用 | |
CN108208781A (zh) | 一种修复肝损伤、增强免疫力的蛹虫草组合物及制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: YANG JIE Free format text: FORMER OWNER: XUZHOU HONGYU AGRICULTURAL TECHNOLOGY CO., LTD. Effective date: 20140328 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Wenxia Inventor after: Yang Jie Inventor after: Li Xianglin Inventor after: Zhang Haiyan Inventor after: Shi Yujie Inventor before: Yang Jie Inventor before: Li Xianglin Inventor before: Zhang Haiyan Inventor before: Shi Yujie |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: YANG JIE LI XIANGLIN ZHANG HAIYAN SHI YUJIE TO: HU WENXIA YANG JIE LI XIANGLIN ZHANG HAIYAN SHI YUJIE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140328 Address after: 221200, No. 99, Huanyu West Road, Suining modern agricultural demonstration area, Suining County, Xuzhou, Jiangsu Applicant after: Yang Jie Address before: 221200, No. 99, Huanyu West Road, Suining modern agricultural demonstration area, Suining County, Xuzhou, Jiangsu Applicant before: Xuzhou Hongyu Agricultural Science and Technology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20141218 |
|
EXPY | Termination of patent right or utility model |